The Markets in Crypto-Assets Regulation (MiCA) delivers a new EU-wide regulatory framework for issuing, intermediating and dealing in crypto-assets. Under MiCA, Crypto-asset service providers (CASPs) ...

Everyone receives an annual performance review, at which they are helped to identify training and development needs and set career objectives for the year ahead. In order for you to manage your own ...

The new Chancellor of the Exchequer gave her first Mansion House speech on 14 November 2024. The speech announced a range of measures which aim to: ...

Businesses offering subscription services to UK consumers will need to comply with new laws on subscription contracts in force from April 2025. The Government is consulting on proposed regulations.

Global law firm Clifford Chance has advised the Cypriot defence company THEON International plc ("THEON)" on the acquisition of a 60% controlling stake in Harder Digital group (Harder Digital), a ...

Global law firm Clifford Chance has advised Goldman Sachs, Huatai Financial and JP Morgan (in alphabetical order) as the joint sponsors as well as the underwriters for SF Holding's H share initial ...

On 1 May 2024, Federal Law Decree 51/2023 on Financial Restructuring and Bankruptcy (the "2024 Bankruptcy Law") came into force and replaced the previous 2016 bankruptcy law (the "2016 Bankruptcy Law" ...

The SCC Arbitration Institute published the SCC Guide in October 2024. It is a short and high-level document which seeks to highlight issues that should be considered by the parties and tribunal when ...

The SCC Arbitration Institute published the SCC Guide in October 2024. It is a short and high-level document which seeks to highlight issues that should be considered by the parties and tribunal when ...

It is a fundamental principle of insurance law that policies provide cover for loss caused by the insured peril, and exclude losses caused by an excluded cause. In recent times the English Courts have ...

Global law firm Clifford Chance is advising Charme Capital Partners, a pan-European private equity firm, on the envisaged acquisition of Centogene GmbH, a rare diseases company focused on transforming ...